Vir Biotechnology
499 Illinois Suite 500
San Francisco
California
94158
United States
Website: http://www.vir.bio/
Email: info@vir.com
174 articles about Vir Biotechnology
-
Brii Biosciences is one of many China-based companies that are heavily investing in U.S. biotech and pharmaceutical companies to support the development of programs that could come back to China for approval.
-
CLSA Names Pantheon DiNA Award Winners
10/9/2018
Bristol-Myers Squibb, Nektar Therapeutics, Amgen and others will be recognized for their significant contributions to the California life sciences industry during the November 2018 Pantheon DiNA Awards hosted by the California Life Sciences Association. -
Gilmore O’Neill, formerly Biogen’s senior vice president, late-stage clinical development, jumped ship and will be Sarepta Therapeutics’ chief medical officer.
-
Brii Biosciences Launches with $260 Million, a Partnership with Vir Biotech, and Other Relationsh...
5/24/2018
Brii Biosciences is launching to accelerate the development and delivery of breakthrough drugs in China with $260 million in financial backing. -
Pharmaceutical execs who leave their positions with big pharmaceutical companies, unless opting to retire for good, often move to leadership positions at other big companies. There are other choices.
-
Despite raised awareness over the past few years, the gender diversity gap in the boardrooms of Fortune 1000 companies has remained at slightly less than 20 percent, as of 2017. There is evidence though that shows companies with more diversity at the highest levels see a higher return on investme...
-
Vir Biotechnology Appoints Leading Immunologist Antonio Lanzavecchia, M.D., Senior VP, Senior Research Fellow
12/18/2017
Reporting to CEO George Scangos, Ph.D., Dr. Lanzavecchia will provide scientific leadership for Vir's technical programs that are designed to transform the care of people with serious infectious diseases.
-
Vir Biotechnology Appoints Herbert W. “Skip” Virgin Executive Vice President and Chief Scientific Officer
11/28/2017
The appointment is effective January 1, 2018.
-
Women In Bio Announces That Alpna Seth Joins Bio-Techne's Board of Directors
11/7/2017
WIB launched Boardroom Ready in 2016.
-
George Scangos' Bold Vision
10/25/2017
The former Biogen CEO is making waves at his new venture, Vir Biotechnology. -
Two weeks after securing more than $46M in financing, Visterra struck a deal worth up to $1B with startup Vir Biotech.
-
Vir Biotechnology Builds Pipeline, Capabilities, And Lays Out Strategy To Address Serious Infectious Diseases
10/18/2017
Vir Biotechnology, Inc. today announced agreements with Humabs BioMed SA, Alnylam Pharmaceuticals, Inc., and Visterra, Inc., as well as four leading academic research institutions.
-
Alnylam and startup Vir Biotech inked a deal worth up to $1B for the development and marketing of RNAi therapies aimed at treating infectious diseases including HBV.
-
Former Biogen CEO to Helm Newly Launched Bay Area Startup Vir Biotechnology
1/9/2017